Natco Pharma secures USFDA nod for Trabectedin for Injection Ruchika Sharma18 Aug 2022 11:23 AM ISTHyderabad: Drugmaker, Natco Pharma Limited has recently announced that the U.S. Food and Drug Administration (USFDA) has granted tentative approval...
Johnson and Johnson cancer drug sales help weather hit from stronger dollar Ruchika Sharma20 July 2022 2:00 PM ISTThe company said it was raising prices of some products like painkillers and mouthwash in response to inflation.
Roche anti-cancer drug Atezolizumab gets CDSCO panel nod for Metastatic Triple Negative Breast Cancer Rahul Verma15 July 2022 4:53 PM ISTBased on the justification provided by the pharmaceutical giant Roche, the Subject Expert Committee (SEC) functional under Central Drug Standard...
Merck in advanced talks to buy Seagen in nearly USD 40-billion deal: WSJ Ruchika Sharma10 July 2022 12:00 PM ISTThe companies are seeking to seal the deal on or before the announcement of Merck's second-quarter earnings set for July 28, according to the WSJ...
Cancer drug which shows potential as treatment for muscular dystrophy Isra Zaman1 July 2022 9:15 AM ISTResearchers at the University of British Columbia's School of Biomedical Engineering have discovered that an existing cancer drug could have potential...
Urgent need to reduce GST on cancer drugs: Parliament members Ruchika Sharma28 Jun 2022 10:00 AM ISTMembers expressed their concern about the availability for facilities and urged to conduct a PET scan which is a crucial way to detect cancer.
Bristol Myers Squibb must face USD 6.4 billion lawsuit over delayed cancer drug Ruchika Sharma25 Jun 2022 3:30 PM ISTThe case arose from the company's agreement to pay Celgene shareholders holding "contingent value rights" an extra $9 per share in cash if it won U.S....
USFDA nod to Alembic Pharma cancer drug Dasatinib Ruchika Sharma10 Jun 2022 12:58 PM ISTVadodara: Drugmaker, Alembic Pharmaceuticals Limited, today announced that the company has received tentative approval from the US Food & Drug...
Gilead Sciences drug Trodelvy modestly delays breast cancer progression in late-stage trial Ruchika Sharma6 Jun 2022 4:09 PM ISTWall Street analysts, on average, expect annual sales of the drug will top $2 billion 2026, according to Refinitiv.
Novartis Kymriah gets USFDA nod for relapsed or refractory follicular lymphoma Ruchika Sharma30 May 2022 12:19 PM IST"Kymriah is now FDA approved in three indications and remains the only CAR-T cell therapy approved in both adult and pediatric settings," claims the...
Eli Lilly Kinsale gets CDSCO panel nod to import, market anticancer drug Selpercatinib Dr. Divya Colin20 May 2022 5:52 PM ISTNew Delhi: Granting the clinical trial waiver, the Subject Expert Committee ( SEC) of the Central Drugs Standard Control Organization (CDSCO) has...
Gland Pharma launches cancer drug Bortezomib in US Ruchika Sharma5 May 2022 12:06 PM ISTHyderabad: Gland Pharma Limited, a generic injectable focused pharmaceutical company, through its partner has launched Bortezomib for Injection, 3.5 ...
